Cargando…
Structural Biology of LRRK2 and its Interaction with Microtubules
Mutations in leucine rich repeat kinase 2 (LRRK2) are a major cause of familial Parkinson's disease (PD) and a risk factor for its sporadic form. LRRK2 hyperactivity has also been reported in sporadic PD, making LRRK2 an appealing target for PD small‐molecule therapeutics. At a cellular level,...
Autores principales: | Leschziner, Andres E., Reck‐Peterson, Samara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290818/ https://www.ncbi.nlm.nih.gov/pubmed/34423856 http://dx.doi.org/10.1002/mds.28755 |
Ejemplares similares
-
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
por: Snead, David M., et al.
Publicado: (2022) -
Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction
por: Deniston, CK, et al.
Publicado: (2020) -
Structure of LRRK1 and mechanisms of autoinhibition and activation
por: Reimer, Janice M., et al.
Publicado: (2023) -
Lis1 Acts as a “Clutch” between the ATPase and Microtubule-Binding Domains of the Dynein Motor
por: Huang, Julie, et al.
Publicado: (2012) -
Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor
por: Bright, Jessica M., et al.
Publicado: (2021)